+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Monoclonal antibodies that recognize human granulocyte-macrophage colony-stimulating factor and neutralize its bioactivity in vitro



Monoclonal antibodies that recognize human granulocyte-macrophage colony-stimulating factor and neutralize its bioactivity in vitro



Hybridoma 9(6): 545-558



We have produced monoclonal antibodies to bacterially synthesized, human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and have studied in detail the characteristics of three strongly neutralizing antibodies. The antibodies reacted with GM-CSF at high dilution (EC50 = 0.1-1.7 nM) in an indirect ELISA but did not react with murine GM-CSF or other cytokines. They also recognized glycosylated hGM-CSF produced by human lymphocytes. The antibodies were able to immunoprecipitate rhGM-CSF, but only reacted weakly with rhGM-CSF on Western blots, indicating that they recognized a conformation-dependent epitope. Cross-blocking studies showed that the three antibodies recognized overlapping epitopes. The antibodies inhibited binding of 125I-labeled rhGM-CSF to HL-60 cells at nanomolar concentrations and neutralized GM-CSF activity in two different bioassays. These antibodies thus provide a useful tool for analyzing the specificity of bioassays and for further studies of the production and function of GM-CSF in vitro and in vivo.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040730384

Download citation: RISBibTeXText

PMID: 1706312

DOI: 10.1089/hyb.1990.9.545


Related references

Failure to detect interleukin (IL)-3 mRNA or protein in human keratinocytes: antibodies to granulocyte macrophage-colony-stimulating factor or IL-6 (but not IL-3) neutralize "IL-3" bioactivity. Journal of Investigative Dermatology 104(3): 335-339, 1995

Two neutralizing monoclonal antibodies against human granulocyte-macrophage colony-stimulating factor recognize the receptor binding domain of the molecule. Journal of Immunology 144(6): 2184-2189, 1990

Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies. Cancer Immunology Immunotherapy. 39(4): 254-262, 1994

Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. International Journal of Molecular Medicine 2(4): 471-475, 1998

The proliferative effects of human granulocyte macrophage colony stimulating factor alpha and granulocyte macrophage colony stimulating factor beta and murine granulocyte colony stimulating factor in microwell cultures of fractionated human marrow cells. Leukemia Research 9(5): 521-528, 1985

Retinoic acid acts to neutralize the inhibitory effect of granulocyte macrophage colony stimulating factor gm csf on alkaline phosphatase activity of neutrophils that is induced by granulocyte colony stimulating factor g csf. Experimental Hematology (Charlottesville) 20(4): 482-485, 1992

Enzyme immunoassay for human granulocyte-macrophage colony-stimulating factor using monoclonal antibodies. Bioorganicheskaya Khimiya 25(9): 673-678, 1999

Immunoenzyme determination of human granulocyte-macrophage colony-stimulating factor using monoclonal antibodies. Bioorganicheskaia Khimiia 25(9): 673-678, 1999

Thrombin stimulates synthesis of macrophage colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor by human proximal tubular epithelial cells in culture. Nephron Extra 2(1): 1-8, 2012

Mechanism of synergy between granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in colony formation from human marrow cells in vitro. Experimental Hematology 17(7): 816-821, 1989

Identification of functionally distinct domains of human granulocyte-macrophage colony-stimulating factor using monoclonal antibodies. Blood 77(5): 1033-1043, 1991

Synergy of human granulocyte macrophage colony stimulating factor and human granulocyte colony stimulating factor on the colony formation of marrow cells in vitro. Experimental Hematology 16(6): 554, 1988

Differentiation of human monocytes in vitro with granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor produces distinct changes in cGMP phosphodiesterase expression. Cellular Signalling 16(3): 365-374, 2004

Neutralizing and nonneutralizing monoclonal antibodies to the human granulocyte-macrophage colony-stimulating factor receptor alpha-chain. Blood 82(6): 1724-1731, 1993

Transcriptional rates of granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, interleukin-3, and macrophage colony-stimulating factor genes in activated cord versus adult mononuclear cells: alteration in cytokine expression may be secondary to posttranscriptional instability. Pediatric Research 34(5): 560-564, 1993